<DOC>
	<DOCNO>NCT00343096</DOCNO>
	<brief_summary>This study aim address hypothesis Lorazepam ( anticonvulsant ) effective give via intranasal buccal route intravenous route terminate convulsion child .</brief_summary>
	<brief_title>Randomized Trial Comparing 3 Routes Delivering Lorazepam Children .</brief_title>
	<detailed_description>Convulsions common child . Prompt treatment effective anticonvulsant reduces longterm morbidity mortality . The use intravenous lorazepam first line therapy acute childhood convulsion venous access obtain widely accept developed country . However , intravenous access problem hospital small child . Benzodiazepines Lorazepam long mainstay first line therapy acute convulsion insufficient clinical evidence optimal mode administration venous access fail . Lorazepam give via intranasal buccal route offer potential effective intravenous lorazepam whilst easy administer avoid need intravenous cannulation . To date large publish study evaluate efficacy safety intranasal buccal lorazepam compare intravenous lorazepam treatment acute convulsion . In study wish address urgent need obtain randomized control data treat acute convulsion child use drug delivery system safe , effective easy use setting .</detailed_description>
	<mesh_term>Status Epilepticus</mesh_term>
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Lorazepam</mesh_term>
	<criteria>child acute generalized seizure , continue minimum 5 minute , receive anticonvulsant therapy within 1 hour presentation . Children receive anticonvulsant treatment within 1 hour prior assessment . Any child whose seizure cease follow correction hypoglycaemia . Children known adverse reaction lorazepam .</criteria>
	<gender>All</gender>
	<minimum_age>2 Months</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>intranasal</keyword>
	<keyword>buccal</keyword>
	<keyword>lorazepam</keyword>
	<keyword>paediatric</keyword>
	<keyword>convulsion</keyword>
</DOC>